AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence

Zhongya Wang, Leszek Lisowski, Milton J. Finegold, Hiroyuki Nakai, Mark A. Kay, Markus Grompe

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ∼1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ∼30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.

Original languageEnglish (US)
Pages (from-to)1902-1911
Number of pages10
JournalMolecular Therapy
Volume20
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Ribosomal DNA
Transgenes
Inborn Genetic Diseases
Tyrosinemias
Liver Regeneration
Factor IX
Homologous Recombination
Genetic Therapy
Hepatocytes
Complementary DNA

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Genetics
  • Drug Discovery
  • Pharmacology

Cite this

AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence. / Wang, Zhongya; Lisowski, Leszek; Finegold, Milton J.; Nakai, Hiroyuki; Kay, Mark A.; Grompe, Markus.

In: Molecular Therapy, Vol. 20, No. 10, 10.2012, p. 1902-1911.

Research output: Contribution to journalArticle

Wang, Zhongya ; Lisowski, Leszek ; Finegold, Milton J. ; Nakai, Hiroyuki ; Kay, Mark A. ; Grompe, Markus. / AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence. In: Molecular Therapy. 2012 ; Vol. 20, No. 10. pp. 1902-1911.
@article{1d094a4e68724013ae1a0baf9e3b4f53,
title = "AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence",
abstract = "Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ∼1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ∼30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.",
author = "Zhongya Wang and Leszek Lisowski and Finegold, {Milton J.} and Hiroyuki Nakai and Kay, {Mark A.} and Markus Grompe",
year = "2012",
month = "10",
doi = "10.1038/mt.2012.157",
language = "English (US)",
volume = "20",
pages = "1902--1911",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence

AU - Wang, Zhongya

AU - Lisowski, Leszek

AU - Finegold, Milton J.

AU - Nakai, Hiroyuki

AU - Kay, Mark A.

AU - Grompe, Markus

PY - 2012/10

Y1 - 2012/10

N2 - Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ∼1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ∼30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.

AB - Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ∼1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ∼30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.

UR - http://www.scopus.com/inward/record.url?scp=84866930809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866930809&partnerID=8YFLogxK

U2 - 10.1038/mt.2012.157

DO - 10.1038/mt.2012.157

M3 - Article

C2 - 22990673

AN - SCOPUS:84866930809

VL - 20

SP - 1902

EP - 1911

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 10

ER -